azacitidine has been researched along with Granulocytic Leukemia, Chronic, Stable Phase in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beckeriche, F; Benbrahim, O; Cano, I; Cony-Makhoul, P; De Botton, S; de Gunzburg, N; Farhat, H; Garcia, I; Ghez, D; Ghez, S; Lara, D; Oberkampf, F; Raggueneau, V; Rigaudeau, S; Rousselot, P; Ruggiu, M; Spentchian, M; Taksin, AL; Terre, C | 1 |
| Matsuo, T; Tomonaga, M | 1 |
1 review(s) available for azacitidine and Granulocytic Leukemia, Chronic, Stable Phase
| Article | Year |
|---|---|
[Chemotherapy and radiation therapy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Azacitidine; Busulfan; Decitabine; Harringtonines; Homoharringtonine; Humans; Hydroxyurea; Leukemia, Myeloid, Chronic-Phase | 2001 |
1 other study(ies) available for azacitidine and Granulocytic Leukemia, Chronic, Stable Phase
| Article | Year |
|---|---|
Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Biomarkers; Combined Modality Therapy; Cytogenetic Analysis; Female; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Chronic-Phase; Male; Neoplasm Staging; Protein Kinase Inhibitors; Transplantation, Homologous; Treatment Outcome | 2018 |